Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Ferguson

Showing results (81-90 of 219) with videos related to

Pageof 22
Sort By:
Transplantation|January 1, 1994
Alloantigenicity of human endothelial cells. II. Analysis of interleukin 2 production and proliferation by T cells after contact with allogeneic endotheliaP W Adams, H S Lee, R M Ferguson, et al.
Current Surgery|November 1, 1980
The relative immunogenicity of murine tissues in vivoS E Maizel, D A Vallera, S J Mentzer, et al.
Transplantation Proceedings|December 1, 1989
The influence of recipient race on renal allograft survival: a single institution analysisB G Sommer, D E Sing, M L Henry, et al.
Transplantation Proceedings|April 1, 1990
Improved immediate renal allograft function after initial simple cold storageM L Henry, B G Sommer, R J Tesi, et al.
Transplantation Proceedings|February 1, 1993
Trial of cyclosporine vs OG37-325 in cadaveric renal transplantation: a preliminary reportM L Henry, R J Tesi, E A Elkhammas, et al.
Transplantation|December 1, 1988
Recipient endothelialization of renal allografts. An immunohistochemical study utilizing blood group antigensD D Sedmak, H M Sharma, C M Czajak, et al.
Transplantation Proceedings|April 1, 1986
Cyclosporine blood level monitoring: the early posttransplant periodR M Ferguson, D M Canafax, R T Sawchuck, et al.
Surgery|August 1, 1986
Identification and treatment of cyclosporine-associated allograft thrombosisR E Schlanger, M L Henry, B G Sommer, et al.
Transplantation|February 3, 1998
In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant modelG L Bumgardner, J Li, M Heininger, et al.
Clinical Transplantation|July 25, 2007
Clinical outcomes of renal transplant recipients treated with enteric-coated mycophenolic acid vs. mycophenolate mofetil as a switch agent using a primary steroid-free rapamune and microemulsion cyclosporine protocolR P Pelletier, J Soule, M L Henry, et al.
Pageof 22

Showing results (81-90 of 219) with videos related to

Sort By:
Pageof 22
Transplantation|January 1, 1994
Alloantigenicity of human endothelial cells. II. Analysis of interleukin 2 production and proliferation by T cells after contact with allogeneic endotheliaP W Adams, H S Lee, R M Ferguson, et al.
Current Surgery|November 1, 1980
The relative immunogenicity of murine tissues in vivoS E Maizel, D A Vallera, S J Mentzer, et al.
Transplantation Proceedings|December 1, 1989
The influence of recipient race on renal allograft survival: a single institution analysisB G Sommer, D E Sing, M L Henry, et al.
Transplantation Proceedings|April 1, 1990
Improved immediate renal allograft function after initial simple cold storageM L Henry, B G Sommer, R J Tesi, et al.
Transplantation Proceedings|February 1, 1993
Trial of cyclosporine vs OG37-325 in cadaveric renal transplantation: a preliminary reportM L Henry, R J Tesi, E A Elkhammas, et al.
Transplantation|December 1, 1988
Recipient endothelialization of renal allografts. An immunohistochemical study utilizing blood group antigensD D Sedmak, H M Sharma, C M Czajak, et al.
Transplantation Proceedings|April 1, 1986
Cyclosporine blood level monitoring: the early posttransplant periodR M Ferguson, D M Canafax, R T Sawchuck, et al.
Surgery|August 1, 1986
Identification and treatment of cyclosporine-associated allograft thrombosisR E Schlanger, M L Henry, B G Sommer, et al.
Transplantation|February 3, 1998
In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant modelG L Bumgardner, J Li, M Heininger, et al.
Clinical Transplantation|July 25, 2007
Clinical outcomes of renal transplant recipients treated with enteric-coated mycophenolic acid vs. mycophenolate mofetil as a switch agent using a primary steroid-free rapamune and microemulsion cyclosporine protocolR P Pelletier, J Soule, M L Henry, et al.
Pageof 22